The presence of melatonin receptors and inhibitory effect of melatonin on hydrogen peroxide-induced endothelial nitric oxide synthase expression in bovine cerebral blood vessels

Journal of Pineal Research

Volumn 43, Issue 1, 2007, Pages 35-41

  Chucharoen, Prapapun ^a   Chetsawang, Banthit ^a   Putthaprasart, Chorkaew ^a   Srikiatkhachorn, Anan ^b   Govitrapong, Piyarat ^a,c  

^a MAHIDOL UNIVERSITY   (Thailand)

^b CHULALONGKORN UNIVERSITY   (Thailand)

^c MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Bovine; Cerebral arteries; Gene expression; Melatonin receptors; Neuroprotection; Nitric oxide synthase

Indexed keywords

HYDROGEN PEROXIDE; INDUCIBLE NITRIC OXIDE SYNTHASE; IODINE 125; IODOMELATONIN; MELATONIN; MELATONIN 1 RECEPTOR; MELATONIN DERIVATIVE; MELATONIN RECEPTOR; MESSENGER RNA; PROTEIN KINASE (CALCIUM,CALMODULIN) II; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ANTERIOR CEREBRAL ARTERY; ARTICLE; BINDING AFFINITY; BINDING ASSAY; BIOASSAY; BRAIN ARTERY; BRAIN BLOOD VESSEL; COMPARATIVE STUDY; CONTROLLED STUDY; COW; DNA SEQUENCE; ENZYME INHIBITION; ENZYME PHOSPHORYLATION; ENZYME RELEASE; GENE EXPRESSION; HORMONE ACTION; MIDDLE CEREBRAL ARTERY; NEUROMODULATION; NEUROPHYSIOLOGY; NONHUMAN; NUCLEOTIDE SEQUENCE; POSTERIOR CEREBRAL ARTERY; RECEPTOR BINDING; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VERTEBRAL ARTERY;

ANIMALS; CATTLE; CEREBRAL ARTERIES; FEMALE; HYDROGEN PEROXIDE; MELATONIN; NITRIC OXIDE SYNTHASE TYPE III; RECEPTORS, MELATONIN; RNA, MESSENGER; TELENCEPHALON;

EID: 34447126472     PISSN: 07423098     EISSN: 1600079X     Source Type: Journal    
DOI: 10.1111/j.1600-079X.2007.00440.x     Document Type: Article

References (39)

1. Reiter RJ. Pineal melatonin: cell biology of its synthesis and of its physiological interactions. Endocr Rev 1991 12 : 151 180.
2. Morgan PJ, Barrett P, Howell HE et al. Melatonin receptors: localization, molecular pharmacology and physiological significance. Neurochem Int 1994 24 : 101 146.
3. Nosjean O, Nicolas JP, Klupsch F et al. Comparative pharmacological studies of melatonin receptors: MT1, MT2 and MT3/QR2. Tissue distribution of MT3/QR2. Biochem Pharmacol 2001 61 : 1369 1379.
4. Viswanathan M, Laitinen JT, Saavedra JM. Expression of melatonin receptors in arteries involved in thermoregulation. Proc Natl Acad Sci U S A 1990 87 : 6200 6203.
5. Regrigny O, Delagrange P, Scalbert E et al. Effects of melatonin on rat pial arteriolar diameter in vivo. Br J Pharmacol 1999 127 : 1666 1670.
6. Viswanathan M. Melatonin inhibits calcitonin gene-related peptide-induced vasodilation and increase in cAMP in rat middle cerebral arteries. Eur J Pharmacol 2001 415 : 247 250.
7. Capsoni S, Viswanathan M, De Oliveria AM et al. Characterization of melatonin receptors and signal transduction system in rat arteries forming the circle of Willis. Endocrinology 1994 135 : 373 378.
8. Touyz RM, Schiffrin EL. Reactive oxygen species in vascular biology: implications in hypertension. Histochem Cell Biol 2004 122 : 339 352.
9. Ha MK, Chung KY, Bang D et al. Proteomic analysis of the proteins expressed by hydrogen peroxide treated cultured human dermal microvascular endothelial cells. Proteomics 2005 5 : 1507 1519.
10. Iadecola C. Does nitric oxide mediate the increases in cerebral blood flow elicited by hypercapnia? Proc Natl Acad Sci U S A 1992 89 : 3913 3916.
11. Niwa M, Inao S, Takayasu M et al. Time course of expression of three nitric oxide synthase isoforms after transient middle cerebral artery occlusion in rats. Neurol Med Chir 2001 41 : 63 72.
12. Veltkamp R, Rajapakse N, Robins G et al. Transient focal ischemia increase endothelial nitric oxide synthase in cerebral blood vessels. Stroke 2002 33 : 2704 2710.
13. Pei Z, Fung PCW, Cheung RTF. Melatonin reduces nitric oxide level during ischemia but not blood-brain barrier breakdown during reperfusion in a rat middle cerebral artery occlusion stroke model. J Pineal Res 2003 34 : 110 118.
14. Chen LJ, Gao YQ, Li XJ et al. Melatonin protects against MPTP/MPP+-induced mitochondrial DNA oxidative damage in vivo and in vitro. J Pineal Res 2005 39 : 34 42.
15. Alvira D, Tajes M, Verdaguer E et al. Inhibition of the cdk5/p25 fragment formation may explain the antiapoptotic effects of melatonin in an experimental model of Parkinson's disease. J Pineal Res 2006 40 : 251 258.
16. Bettahi I, Pozo D, Osuna C et al. Melatonin reduces nitric oxide synthase activity in rat hypothalamus. J Pineal Res 1996 20 : 205 210.
17. Bradford MM. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976 72 : 248 254.
18. Ebisa T, Karne S, Lerner MR et al. Expression cloning of a high-affinity melatonin receptor from Xenopus dermal melanophores. Proc Natl Acad Sci U S A 1994 91 : 6133 6137.
19. Reppert SM, Weaver DR, Ebisawa T. Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses. Neuron 1994 13 : 1177 1185.
20. Ting KN, Blaylock NA, Sugden D et al. Molecular and pharmacological evidence for MT1 melatonin receptor subtype in the tail artery of juvenile Wistar rats. Br J Pharmacol 1999 127 : 987 995.
21. Savaskan E, Olivieri G, Brydon L et al. Cerebrovascular melatonin MT1-receptor alterations in patients with Alzheimer's disease. Neurosci Lett 2001 308 : 9 12.
22. Wu YH, Swaab DF. The human pineal gland and melatonin in aging and Alzheimer's disease. J Pineal Res 2005 38 : 145 152.
23. Brun J, Claustrat B, Saddier P et al. Nocturnal melatonin excretion is decreased in patients with migraine without aura attacks associated with menses. Cephalalgia 1995 15 : 136 139.
24. Fiorina P, Lattuada G, Ponari O et al. Impaired nocturnal melatonin excretion and changes of immunological status in ischaemic stroke patients. Lancet 1996 347 : 692 693.
25. Szabo C. Physiological and pathophysiological roles of nitric oxide in the central nervous system. Brain Res Bull 1996 41 : 131 141.
26. Yun HY, Dawson VL, Dawson TM. Neurobiology of nitric oxide. Crit Rev Neurobiol 1996 10 : 291 316.
27. Iadecola C, Ross ME. Molecular pathology of cerebral ischemia: delayed gene expression and strategies for neuroprotection. Ann N Y Acad Sci 1997 835 : 203 217.
28. Bredt DS. Endogenous nitric oxide synthesis: biological functions and pathophysiology. Free Radic Res 1999 31 : 577 596.
29. Shaikh AY, Xu J, Wu Y et al. Melatonin protects bovine cerebral endothelial cells from hyperoxia-induced DNA damage and death. Neurosci Lett 1997 229 : 193 197.
30. Choi YJ, Lee MK, Lee YJ et al. Inhibition of hydrogen peroxide-induced endothelial apoptosis by 2′,4′,7-trihydroxyflavanone, a flavonoid form. J Med Food 2004 7 : 408 416.
31. Onuki J, Almeida EA, Medeiros MH et al. Inhibition of 5-aminolevulinic acid-induced DNA damage by melatonin, N1-acetyl-N2-formyl-5-methoxykynuramine, quercetin or resveratrol. J Pineal Res 2005 38 : 107 115.
32. Guenther AL, Schmidt SI, Laatsch H et al. Reaction of the melatonin metabolite AMK (N1-acetyl-5-methoxykynuramine) with reactive nitrogen species: formation of novel compound, 3-acetamidomethyl-6-methoxycinnolinone and 3-nitro-AMK. J Pineal Res 2005 : 39 : 251 260.
33. Pozo D, Reiter RJ, Calvo JR et al. Inhibition of cerebellar nitric oxide synthase and cyclic GMP production by melatonin via complex formation with calmodulin. J Cell Biochem 1997 65 : 430 442.
34. Cai H, Davis ME, Drummond GR et al. Induction of endothelial NO synthase by hydrogen peroxide via a Ca(2+)/calmodulin-dependent protein kinaseII/Janus kinase 2-dependent pathway. Arterioscler Thromb Vasc Biol 2001 21 : 1571 1576.
35. Cai H, Mcnally JS, Weber M et al. Oscillatory shear stress upregulation of endothelial nitric oxide synthase requires intracellular hydrogen peroxide and CaMKII. J Mol Cell Cardiol 2004 37 : 121 125.
36. Tan DX, Manchester LC, Reiter RJ et al. Melatonin directly scavenges hydrogen peroxide: a potentially new metabolic pathway of melatonin biotransformation. Free Radic Biol Med 2000 29 : 1177 1185.
37. Budenik GA, Blask DE, Brown GM et al. Prospects of the clinical utilization of melatonin. Biol Signals Recept 1998 7 : 195 219.
38. Fiorina P, Lattuada G, Ponari O et al. Impaired nocturnal melatonin excretion and changes of immunological status in ischemic stroke patients. Lancet 1996 347 : 692 693.
39. Manev H, Uz T, Kharlamov A et al. Increased brain damage after stroke or excitotoxic seizures in melatonin-deficient rats. FASEB J 1996 10 : 1546 1551.